These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37786919)

  • 41. Interventions targeted at oxidatively generated modifications of nucleic acids focused on urine and plasma markers.
    Larsen EL; Weimann A; Poulsen HE
    Free Radic Biol Med; 2019 Dec; 145():256-283. PubMed ID: 31563634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of mass spectrometry in genomics.
    Meng Z; Simmons-Willis TA; Limbach PA
    Biomol Eng; 2004 Jan; 21(1):1-13. PubMed ID: 14715314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Locked and unlocked nucleosides in functional nucleic acids.
    Doessing H; Vester B
    Molecules; 2011 May; 16(6):4511-26. PubMed ID: 21629180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantification of Modified Nucleosides in the Context of NAIL-MS.
    Heiss M; Borland K; Yoluç Y; Kellner S
    Methods Mol Biol; 2021; 2298():279-306. PubMed ID: 34085252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mass spectrometry of nucleic acids in molecular medicine].
    Il'ina EN; Govorun VM
    Bioorg Khim; 2009; 35(2):149-64. PubMed ID: 19537166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nucleic Acid analysis by fourier transform ion cyclotron resonance mass spectrometry at the beginning of the twenty-first century.
    Frahm JL; Muddiman DC
    Curr Pharm Des; 2005; 11(20):2593-613. PubMed ID: 16101461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in therapeutic nucleic acids and their analytical methods.
    Talap J; Zhao J; Shen M; Song Z; Zhou H; Kang Y; Sun L; Yu L; Zeng S; Cai S
    J Pharm Biomed Anal; 2021 Nov; 206():114368. PubMed ID: 34571322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) to Quantify Modified Nucleosides.
    Rodell R; Tsao N; Ganguly A; Mosammaparast N
    Methods Mol Biol; 2022; 2444():125-140. PubMed ID: 35290635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways.
    Deng Y; Wang Y; Li L; Miao EA; Liu P
    Front Immunol; 2022; 13():898724. PubMed ID: 35795661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Not all 2',4'-bridged modifications stabilize DNA/RNA duplexes.
    Akita T; Tomita-Sudo E; Itoh S; Sakimoto N; Masuda T; Nakamura A; Onishi Y; Koizumi M; Kawakami J
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(1):57-64. PubMed ID: 37424260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The current perspective and opportunities of small nucleic acid-based therapeutics.
    Chen Y; Li Y; Li C; Zhang D; Liu Y; Zhang J; Guan S; Ding X; Xiao Q
    Drug Dev Res; 2024 Apr; 85(2):e22164. PubMed ID: 38411296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tellurium-Modified Nucleosides, Nucleotides, and Nucleic Acids with Potential Applications.
    Chen C; Huang Z
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MALDI mass spectrometry for nucleic acid analysis.
    Gao X; Tan BH; Sugrue RJ; Tang K
    Top Curr Chem; 2013; 331():55-77. PubMed ID: 23019094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of nucleic acid extraction platforms on hepatitis virus genome detection.
    Pauly MD; Kamili S; Hayden TM
    J Virol Methods; 2019 Nov; 273():113715. PubMed ID: 31419455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensitive, Efficient Quantitation of 13C-Enriched Nucleic Acids via Ultrahigh-Performance Liquid Chromatography-Tandem Mass Spectrometry for Applications in Stable Isotope Probing.
    Wilhelm R; Szeitz A; Klassen TL; Mohn WW
    Appl Environ Microbiol; 2014 Dec; 80(23):7206-11. PubMed ID: 25217022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nucleos'ID: A New Search Engine Enabling the Untargeted Identification of RNA Post-transcriptional Modifications from Tandem Mass Spectrometry Analyses of Nucleosides.
    Gosset-Erard C; Didierjean M; Pansanel J; Lechner A; Wolff P; Kuhn L; Aubriet F; Leize-Wagner E; Chaimbault P; François YN
    Anal Chem; 2023 Jan; 95(2):1608-1617. PubMed ID: 36598775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and properties of a novel modified nucleic acid, 2'-N-methanesulfonyl-2'-amino-locked nucleic acid.
    Sawamoto H; Sasaki T; Takegawa-Araki T; Utsugi M; Furukawa H; Hirakawa Y; Yamairi F; Kurita T; Murahashi K; Yamada K; Ohta T; Kumagai S; Takemiya A; Obika S; Kotera J
    Bioorg Med Chem Lett; 2023 May; 88():129289. PubMed ID: 37068560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.
    Karkare S; Bhatnagar D
    Appl Microbiol Biotechnol; 2006 Aug; 71(5):575-86. PubMed ID: 16683135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mass Spectrometric Analysis of Mitochondrial RNA Modifications.
    Ishigami Y; Suzuki T; Suzuki T
    Methods Mol Biol; 2021; 2192():89-101. PubMed ID: 33230768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrated sample-to-detection chip for nucleic acid test assays.
    Prakash R; Pabbaraju K; Wong S; Tellier R; Kaler KV
    Biomed Microdevices; 2016 Jun; 18(3):44. PubMed ID: 27165104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.